Hybio Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Hybio Pharmaceutical Co., Ltd. is publicly traded on SHZ under the ticker 300199.SZ.
Established in 1998 and headquartered in Shenzhen, China, Hybio Pharmaceutical Co., Ltd. specializes in the global research, development, manufacturing, and commercialization of therapeutic peptide active pharmaceutical ingredients (APIs) and polypeptide medications. Its diverse product range addresses therapeutic needs such as diabetes (including liraglutide, semaglutide, and exenatide), gastrointestinal and...
Can you invest in Hybio Pharmaceutical Co., Ltd.?
Yes. Hybio Pharmaceutical Co., Ltd. trades publicly on SHZ as 300199.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hybio Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.